Financials
- Market Capitalization 364.22 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
1.01
売上高対価格比率
0.81
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3130 | IRD Opus Genetics, Inc. - Common Stock | 4.45 USD | +16.19% | +14.99% | +21.25% | +19.62% | 370.22 M USD | ||
| 3137 | LYEL Lyell Immunopharma, Inc. - Common Stock | 14.96 USD | +2.96% | +2.12% | +16.24% | -38.16% | 366.60 M USD | ||
| 3143 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.75 USD | +4.65% | +1.05% | +2.27% | +27.60% | 364.00 M USD | ||
| 3182 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.50 USD | +5.04% | +0.81% | +11.11% | +44.51% | 348.84 M USD |